Barclays’s Hanover Insurance THG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5M Buy
117,980
+33,993
+40% +$5.91M ﹤0.01% 1092
2025
Q4
$15.4M Buy
83,987
+24,897
+42% +$4.48M ﹤0.01% 1402
2025
Q3
$10.7M Buy
59,090
+24,849
+73% +$4.26M ﹤0.01% 1615
2025
Q2
$5.82M Buy
34,241
+1,974
+6% +$330K ﹤0.01% 1992
2025
Q1
$5.61M Sell
32,267
-2,550
-7% -$413K ﹤0.01% 1819
2024
Q4
$5.38M Buy
34,817
+7,662
+28% +$1.19M ﹤0.01% 2088
2024
Q3
$4.02M Buy
27,155
+10,341
+62% +$1.42M ﹤0.01% 2268
2024
Q2
$2.11M Sell
16,814
-21,559
-56% -$2.8M ﹤0.01% 2096
2024
Q1
$5.23M Buy
38,373
+3,831
+11% +$497K ﹤0.01% 1820
2023
Q4
$4.19M Sell
34,542
-7,851
-19% -$933K ﹤0.01% 2263
2023
Q3
$4.7M Sell
42,393
-601
-1% -$66.2K ﹤0.01% 1353
2023
Q2
$4.86M Buy
42,994
+23,099
+116% +$2.74M ﹤0.01% 1366
2023
Q1
$2.56M Buy
19,895
+1,483
+8% +$199K ﹤0.01% 2011
2022
Q4
$2.49M Buy
18,412
+1,228
+7% +$171K ﹤0.01% 2105
2022
Q3
$2.2M Sell
17,184
-9,797
-36% -$1.32M ﹤0.01% 1684
2022
Q2
$3.95M Sell
26,981
-2,291
-8% -$336K ﹤0.01% 1464
2022
Q1
$4.38M Sell
29,272
-9,642
-25% -$1.35M ﹤0.01% 1322
2021
Q4
$5.1M Sell
38,914
-39,996
-51% -$5.19M ﹤0.01% 1695
2021
Q3
$10.2M Buy
78,910
+32,565
+70% +$4.44M ﹤0.01% 1181
2021
Q2
$6.29M Buy
46,345
+18,639
+67% +$2.56M ﹤0.01% 1462
2021
Q1
$3.59M Buy
27,706
+6,029
+28% +$727K ﹤0.01% 1796
2020
Q4
$2.53M Buy
21,677
+12,344
+132% +$1.33M ﹤0.01% 2058
2020
Q3
$870K Sell
9,333
-16,216
-63% -$1.61M ﹤0.01% 2811
2020
Q2
$2.59M Buy
25,549
+5,284
+26% +$518K ﹤0.01% 1873
2020
Q1
$1.84M Sell
20,265
-14,274
-41% -$1.77M ﹤0.01% 2371
2019
Q4
$4.72M Buy
34,539
+8,229
+31% +$1.11M ﹤0.01% 2063
2019
Q3
$3.56M Buy
26,310
+16,167
+159% +$2.12M ﹤0.01% 2188
2019
Q2
$1.3M Sell
10,143
-41,398
-80% -$5.03M ﹤0.01% 3410
2019
Q1
$5.88M Sell
51,541
-2,756
-5% -$317K ﹤0.01% 1541
2018
Q4
$6.34M Buy
54,297
+34,701
+177% +$3.89M ﹤0.01% 1440
2018
Q3
$2.42M Sell
19,596
-30,997
-61% -$3.83M ﹤0.01% 2658
2018
Q2
$6.05M Buy
50,593
+39,889
+373% +$4.74M 0.01% 1580
2018
Q1
$1.26M Buy
10,704
+4,680
+78% +$526K ﹤0.01% 2943
2017
Q4
$650K Sell
6,024
-2,999
-33% -$309K ﹤0.01% 3546
2017
Q3
$874K Buy
9,023
+8,779
+3,598% +$835K ﹤0.01% 3125
2017
Q2
$22K Sell
244
-2,856
-92% -$246K ﹤0.01% 5761
2017
Q1
$279K Sell
3,100
-5,899
-66% -$522K ﹤0.01% 3997
2016
Q4
$819K Buy
8,999
+7,512
+505% +$626K ﹤0.01% 2945
2016
Q3
$112K Sell
1,487
-3,110
-68% -$247K ﹤0.01% 4432
2016
Q2
$388K Sell
4,597
-8,210
-64% -$706K ﹤0.01% 3413
2016
Q1
$1.15M Buy
12,807
+4,368
+52% +$361K ﹤0.01% 2411
2015
Q4
$683K Sell
8,439
-10,513
-55% -$870K ﹤0.01% 2948
2015
Q3
$1.46M Sell
18,952
-3,368
-15% -$267K ﹤0.01% 2392
2015
Q2
$1.65M Sell
22,320
-20,615
-48% -$1.48M ﹤0.01% 2400
2015
Q1
$3.09M Buy
42,935
+8,785
+26% +$622K ﹤0.01% 1939
2014
Q4
$2.42M Sell
34,150
-92,331
-73% -$6.24M ﹤0.01% 2349
2014
Q3
$7.71M Buy
126,481
+103,994
+462% +$6.46M 0.01% 1392
2014
Q2
$1.42M Buy
22,487
+2,561
+13% +$155K ﹤0.01% 2975
2014
Q1
$1.22M Sell
19,926
-8,593
-30% -$503K ﹤0.01% 3038
2013
Q4
$1.68M Sell
28,519
-6,244
-18% -$368K ﹤0.01% 2848
2013
Q3
$1.91M Sell
34,763
-3,908
-10% -$208K ﹤0.01% 2634
2013
Q2
$1.89M Buy
+38,671
New +$1.9M ﹤0.01% 2600

Other funds holding THG

Barclays's THG Position: Q1 2026 in Review

Barclays increased its Hanover Insurance (THG) stake by 40% in Q1 2026, buying an estimated $5.91M and bringing the position to 117,980 shares worth $20.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Barclays first reported a position in THG in Q2 2013 and has held it in 52 quarters since. 504 funds tracked by Wall St. Rank hold THG as of Q1 2026.

  • Barclays held 117,980 shares of Hanover Insurance worth $20.5M as of Q1 2026.
  • Barclays bought 33,993 Hanover Insurance shares in Q1 2026, an estimated $5.91M.
  • Hanover Insurance made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1092 holding.
  • Barclays first reported a position in Hanover Insurance in Q2 2013 and has held it in 52 quarters since.
  • 504 funds tracked by Wall St. Rank held Hanover Insurance as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.